These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 11426450)
1. Psychological impact of receiving a BRCA1/BRCA2 test result. Lodder L; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; van den Ouweland AM; Niermeijer MF Am J Med Genet; 2001 Jan; 98(1):15-24. PubMed ID: 11426450 [TBL] [Abstract][Full Text] [Related]
2. Men at risk of being a mutation carrier for hereditary breast/ovarian cancer: an exploration of attitudes and psychological functioning during genetic testing. Lodder L; Frets PG; Trijsburg RW; Tibben A; Meijers-Heijboer EJ; Duivenvoorden HJ; Wagner A; van Der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF Eur J Hum Genet; 2001 Jul; 9(7):492-500. PubMed ID: 11464240 [TBL] [Abstract][Full Text] [Related]
3. Presymptomatic testing for BRCA1 and BRCA2: how distressing are the pre-test weeks? Rotterdam/Leiden Genetics Working Group. Lodder LN; Frets PG; Trijsburg RW; Meijers-Heijboer EJ; Klijn JG; Duivenvoorden HJ; Tibben A; Wagner A; van der Meer CA; Devilee P; Cornelisse CJ; Niermeijer MF J Med Genet; 1999 Dec; 36(12):906-13. PubMed ID: 10593998 [TBL] [Abstract][Full Text] [Related]
4. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429 [TBL] [Abstract][Full Text] [Related]
5. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145 [TBL] [Abstract][Full Text] [Related]
6. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation. Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241 [TBL] [Abstract][Full Text] [Related]
7. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. van Oostrom I; Meijers-Heijboer H; Lodder LN; Duivenvoorden HJ; van Gool AR; Seynaeve C; van der Meer CA; Klijn JG; van Geel BN; Burger CW; Wladimiroff JW; Tibben A J Clin Oncol; 2003 Oct; 21(20):3867-74. PubMed ID: 14551306 [TBL] [Abstract][Full Text] [Related]
8. Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. DiCastro M; Frydman M; Friedman I; Shiri-Sverdlov R; Papa MZ; Goldman B; Friedman E Am J Med Genet; 2002 Aug; 111(2):147-51. PubMed ID: 12210341 [TBL] [Abstract][Full Text] [Related]
9. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer. Kuschel B; Lux MP; Goecke TO; Beckmann MW Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253 [TBL] [Abstract][Full Text] [Related]
10. Effects of coping style and BRCA1 and BRCA2 test results on anxiety among women participating in genetic counseling and testing for breast and ovarian cancer risk. Tercyak KP; Lerman C; Peshkin BN; Hughes C; Main D; Isaacs C; Schwartz MD Health Psychol; 2001 May; 20(3):217-22. PubMed ID: 11403219 [TBL] [Abstract][Full Text] [Related]
11. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881 [TBL] [Abstract][Full Text] [Related]
12. Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. Wagner Costalas J; Itzen M; Malick J; Babb JS; Bove B; Godwin AK; Daly MB Am J Med Genet C Semin Med Genet; 2003 May; 119C(1):11-8. PubMed ID: 12704633 [TBL] [Abstract][Full Text] [Related]
14. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study. Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with decisions about clinical BRCA1/2 testing. Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234 [TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics affect the impact of an uninformative DNA test result: the course of worry and distress experienced by women who apply for genetic testing for breast cancer. van Dijk S; Timmermans DR; Meijers-Heijboer H; Tibben A; van Asperen CJ; Otten W J Clin Oncol; 2006 Aug; 24(22):3672-7. PubMed ID: 16877736 [TBL] [Abstract][Full Text] [Related]
17. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer. Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764 [TBL] [Abstract][Full Text] [Related]
18. A genetic epidemiological study of carcinoma of the fallopian tube. Aziz S; Kuperstein G; Rosen B; Cole D; Nedelcu R; McLaughlin J; Narod SA Gynecol Oncol; 2001 Mar; 80(3):341-5. PubMed ID: 11263928 [TBL] [Abstract][Full Text] [Related]
19. Psychological distress and quality of life associated with genetic testing for breast cancer risk. Smith AW; Dougall AL; Posluszny DM; Somers TJ; Rubinstein WS; Baum A Psychooncology; 2008 Aug; 17(8):767-73. PubMed ID: 17992698 [TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]